Anti-gp130 transducer monoclonal antibodies specifically inhibiting ciliary neurotrophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor or oncostatin M

Journal of Immunological Methods

Volumn 190, Issue 1, 1996, Pages 21-27

  Gu, Zong Jiang ^a,b,c   Wijdenes, John ^d   Zhang, Xue Guang ^a,b,c   Hallet, Marie Martine ^e   Clement, Claude ^d   Klein, Bernard ^a,b  

^a CNRS   (France)

^b HÔPITAL SAINT ELOI   (France)

^c Department of Radiation Medicine   (China)

^d Diaclone   (France)

^e INSTITUT DE BIOLOGIE   (France)

Author keywords

Ciliary neurotrophic factor; gp130; IL 11; IL 6; Leukemia inhibitory factor; Monoclonal antibody; Oncostatin M; Receptor

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MONOCLONAL ANTIBODY; ONCOSTATIN M;

ARTICLE; CELL LINE; HUMAN; HUMAN CELL; MOLECULAR CLONING; MYELOMA CELL; PLASMACYTOMA; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BASE SEQUENCE; CILIARY NEUROTROPHIC FACTOR; CYTOKINE RECEPTOR GP130; DNA PRIMERS; HUMANS; INTERLEUKIN-11; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; ONCOSTATIN M; PEPTIDES; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 0029914433     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-1759(95)00232-4     Document Type: Article

References (26)

1. Bataille, R., Jourdan, M., Zhang, X.G. and Klein, B. (1989) Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J. Clin. Invest. 84, 2008.
2. Bauer, J. and Hermann, F. (1991) Interleukin-6 in clinical medicine. Ann. Hematol. 62, 203.
3. Breathnach, R. and Harris, B.A. (1983) Plasmids for cloning and expression of full length double-stranded cDNAs under control of the SV40 early or late gene promotor. Nucleic Acids Res. 11, 7119.
4. De Hon, F.D., Ehlers, M., Rose John, S., Ebeling, S.B., Bos, H.K., Aarden, L.A. and Brakenhoff, J.P. (1994) Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells. J. Exp. Med. 180, 2395.
5. Gearing, D.P., Comeau, M.R., Friend, D.J., Gimpel, S.D., Thut, C.J., McGourty, J., Brasher, K.K., King, J.A., Gillis, S., Mosley, B., Ziegler, S.F. and Cosman, D. (1992) The IL-6 signal transducer gp130 : an oncostatin M receptor and affinity converter for the LIF receptor. Science 255, 1434.
6. Harlow, E. and Lane, D. (1988) Antibodies. A Laboratory Manual. Cold Spring Harbor Laboratory, New York.
7. Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T. and Kishimoto, T. (1990) Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149.
8. Hilton, D.J., Hilton, A.A., Raicevic, A., Rakar, S., Harrison-Smith, M., Gough, N.M., Begley, C.G., Metcalf, D., Nicola, N.A. and Willson, T.A. (1994) Cloning of a murine IL-11 receptor α-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 13, 4765.
9. Hirano, T., Akira, S., Taga, T. and Kishimoto, T. (1990) Biological and clinical aspects of interleukin 6. Immunol. Today 11, 443.
10. Ip, N.Y., McClain, J., Barrezueta, N.X., Aldrich, T.H., Pan, L., Li, Y., Wiegand, S.J., Friedman, B., Davis, S. and Yancopoulos, G.D. (1993) The alpha component of the CNTF receptor is required for signaling and defines potential CNTF targets in the adult and during development. Neuron 10, 89.
11. Kaufman, R.J. (1987) High level production of proteins in mammalian cells. In: J.K. Setlow (Ed.), Genetic Engineering: Principles and Methods. Plenum, New York, p. 155.
12. Kishimoto, T., Taga, T. and Akira, S. (1994) Cytokine signal transduction. Cell 76, 253.
13. Klein, B. and Brailly, H. (1995) Cytokine-binding proteins: stimulating antagonists. Immunol. Today 16, 216.
14. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H. and Köhler, G. (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339.
15. Lu, Z.Y., Brochier, J., Wijdenes, J., Brailly, H., Bataille, R. and Klein, B. (1992) High amounts of circulating interleukin (IL)-6 in the form of monomeric immune complexes during anti-IL-6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo. Eur. J. Immunol. 22, 2819.
16. Matrisian, L.N., Bowden, G.T., Kried, P., Fürstenberger, G., Briand, J.P., Leroy, P. and Breathnach, R. (1986) The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc. Natl. Acad. Sci. USA 83, 9413.
17. Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T. and Kishimoto, T. (1993) IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260, 1808.
18. Savino, R., Ciapponi, L., Lahm, A., Demartis, A., Cabibbo, A., Toniatti, C., Delmastro, P., Altamura, S. and Ciliberto, G. (1994) Rational design of a receptor super-antagonist of human interleukin-6. EMBO J. 13, 5863.
19. Takebe, Y., Seiki, M., Fujisawa, J.I., Hoy, P., Yokota, K., Arai, K.I., Yoshida, M. and Arai, N. (1988) SRa promotor: an efficient and versatile mammalian cDNA expression system composed tof the simian virus 40 early promotor and the R-U5 segment of human T-cell leukemia virus type I long terminal repeat. Mol. Cell Biol. 8, 466.
20. Van Snick, J. (1990) Interleukin-6: an overview. Annu. Rev. Immunol. 8, 253.
21. Ward, L.D., Hewlett, G.J., Discolo, G., Yasukawa, K., Hammacher, A., Moritz, R.L. and Simpson, R.J. (1994) High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J Biol. Chem. 269, 23286.
22. Wijdenes, J., Clement, C., Klein, B., Morel-Fourrier, B., VIta, N., Ferrara, P. and Peters, A. (1991) Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies. Mol. Immunol. 28, 1183.
23. Yawata, H., Yasukawa, K., Natsuka, S., Marakami, M., Yamasaki, K., Hibi, M., Taga, T. and Kishimoto, T. (1993) Structure-function analysis of human IL-6 receptor dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. EMBO J. 12, 1705.
24. Yoshida, K., Saito, M., Suematsu, S., Yoshida, N., Kumanogoh, A., Taga, T. and Kishimoto, T. (1993) Disruption of the gene for shared cytokine signal transducer, gp130. Tissue Antigen 42, 339.
25. Zhang, X.G., Gaillard, J.P., Robillard, N., Lu, Z.Y., Gu, Z.J., Jourdan, M., Boiron, J.M., Bataille, R. and Klein, B. (1994a) Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 83, 3654.
26. Zhang, X.G., Gu, Z.J., Lu, Z.Y., Yasukawa, K., Yancopoulos, G.D., Turner, K., Shoyab, M., Taga, T., Kishimoto, T., Bataille, R. and Klein, B. (1994b) Ciliary neurotropic factor, interleukin 11, leukemia inbitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal trasnducer gp130. J. Exp. Med. 179, 1337.